Skip to main navigation Skip to search Skip to main content

Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer

  • F. J. Esteva

Research output: Contribution to journal › Comment/debate › peer-review

Original languageEnglish (US)
Pages (from-to)382-383
Number of pages2
JournalBreast Diseases
Volume21
Issue number4
DOIs
StatePublished - 2010

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this